Suchergebnisse - "Li, Dengju"

  1. 1

    Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2 von Yin, Shiyu, Huang, Ming, Li, Dengju, Tang, Ning

    ISSN: 0929-5305, 1573-742X, 1573-742X
    Veröffentlicht: New York Springer US 01.05.2021
    Veröffentlicht in Journal of thrombosis and thrombolysis (01.05.2021)
    “… Severe coronavirus disease 2019 (COVID-19) is commonly complicated with coagulopathy, the difference of coagulation features between severe pneumonia induced …”
    Volltext
    Journal Article
  2. 2

    Next-generation T cell immunotherapy: overcoming exhaustion, senescence, and suppression von Li, Guangmei, Li, Dengju, Zhu, Xiaojian

    ISSN: 1664-3224, 1664-3224
    Veröffentlicht: Switzerland Frontiers Media S.A 2025
    Veröffentlicht in Frontiers in immunology (2025)
    “… T-cells are a core component of tumor immunotherapy because of their potent ability to identify and kill cancer cells. Yet efficacy is limited by exhaustion, …”
    Volltext
    Journal Article
  3. 3

    Characteristics of emergency patients with markedly elevated D-dimer levels von Tang, Ning, Pan, Yinyin, Xu, Chao, Li, Dengju

    ISSN: 2045-2322, 2045-2322
    Veröffentlicht: London Nature Publishing Group UK 08.05.2020
    Veröffentlicht in Scientific reports (08.05.2020)
    “… Background: Markedly elevated D-dimer levels can occur in emergency patients with various clinical situations, and is likely to indicate the presence of …”
    Volltext
    Journal Article
  4. 4

    Global, regional, and national burden of acute myeloid leukemia, 1990–2021: a systematic analysis for the global burden of disease study 2021 von Zhou, Yeming, Huang, Guiqin, Cai, Xiaoya, Liu, Ying, Qian, Bingxin, Li, Dengju

    ISSN: 2050-7771, 2050-7771
    Veröffentlicht: London BioMed Central 11.09.2024
    Veröffentlicht in Biomarker research (11.09.2024)
    “… Background Acute myeloid leukemia (AML), as the most common subtype of leukemia in adults, is characterised by rapid progression and poor prognosis. In the …”
    Volltext
    Journal Article
  5. 5

    Different manifestations of patients with inhibitors against prothrombin and thrombin von Tang, Ning, Li, Dengju

    ISSN: 0929-5305, 1573-742X, 1573-742X
    Veröffentlicht: New York Springer US 01.01.2020
    Veröffentlicht in Journal of thrombosis and thrombolysis (01.01.2020)
    Volltext
    Journal Article
  6. 6

    Inflammatory abrasion of hematopoietic stem cells: a candidate clue for the post-CAR-T hematotoxicity? von Sun, Ting, Li, Dengju, Huang, Liang, Zhu, Xiaojian

    ISSN: 1664-3224, 1664-3224
    Veröffentlicht: Switzerland Frontiers Media S.A 08.05.2023
    Veröffentlicht in Frontiers in immunology (08.05.2023)
    “… Chimeric antigen receptor T-cell (CAR-T) therapy has shown remarkable effects in treating various hematological malignancies. However, hematotoxicity, …”
    Volltext
    Journal Article
  7. 7

    Comparing the broth enrichment-multiplex lateral flow immunochromatographic assay with real time quantitative PCR for the rapid detection of carbapenemase-producing organisms in rectal swabs von Wang, Yue, Song, Huijuan, Xu, Min, Li, Dengju, Ran, Xiao, Sun, Ziyong, Chen, Zhongju

    ISSN: 1471-2334, 1471-2334
    Veröffentlicht: London BioMed Central 19.06.2023
    Veröffentlicht in BMC infectious diseases (19.06.2023)
    “… Background Rapid and accurate identification of carbapenemase-producing organism (CPO) intestinal carriers is essential for infection prevention and control …”
    Volltext
    Journal Article
  8. 8

    Quercetagetin alleviates inflammatory osteoclastogenesis and collagen antibody-induced arthritis via Nrf2 signaling and Pten/AKT/Nfatc1 axis von Wang, Haojue, Yuan, Tao, Wang, Jingpeng, Li, Dengju, Lee, Wayne Yuk-wai, Li, Ziqing, Sun, Shui

    ISSN: 1478-6362, 1478-6354, 1478-6362
    Veröffentlicht: London BioMed Central 08.03.2025
    Veröffentlicht in Arthritis research & therapy (08.03.2025)
    “… Purpose Quercetagetin, a flavonoid derived from the natural herb Flos eriocauli, is used in traditional Chinese medicine for its fire-purging …”
    Volltext
    Journal Article
  9. 9

    Be cautious to adopt a second CAR T-cell infusion after failure of CD19/CD22 cocktail CAR T-cell therapy in relapsed/refractory B-NHL von Wang, Gaoxiang, Huang, Meijuan, Jiang, Lijun, Zhang, Xiaoying, Wang, Zhenhao, Yu, Qiuxia, Li, Dengju, Yang, Yang, Yang, Xin, Cao, Yang

    ISSN: 1432-0851, 0340-7004, 1432-0851
    Veröffentlicht: Berlin/Heidelberg Springer Berlin Heidelberg 22.03.2025
    Veröffentlicht in Cancer Immunology, Immunotherapy : CII (22.03.2025)
    “… Chimeric antigen receptor (CAR) T-cell infusion (CTI) therapy has emerged as a breakthrough therapy in relapsed/refractory B-cell non-Hodgkin’s lymphoma (R/R …”
    Volltext
    Journal Article
  10. 10

    Chidamide Inhibits Acute Myeloid Leukemia Cell Proliferation by lncRNA VPS9D1-AS1 Downregulation via MEK/ERK Signaling Pathway von Lin, Liman, Que, Yimei, Lu, Pingfan, Li, Huimin, Xiao, Min, Zhu, Xiaojian, Li, Dengju

    ISSN: 1663-9812, 1663-9812
    Veröffentlicht: Frontiers Media S.A 19.10.2020
    Veröffentlicht in Frontiers in pharmacology (19.10.2020)
    “… Irregular histone modification and aberrant lncRNAs expression are closely related to the occurrence of tumors including acute myeloid leukemia (AML). However, …”
    Volltext
    Journal Article
  11. 11

    Short‐Course Blinatumomab Treatment as a Bridge to Further Salvage Therapy for Relapsed/Refractory B‐Cell Acute Lymphoblastic Leukemia: A Retrospective Single‐Center Study von Yin, Jin, Cai, Xiaoya, Qian, Bingxin, Liu, Ying, Li, Dengju

    ISSN: 2045-7634, 2045-7634
    Veröffentlicht: United States John Wiley & Sons, Inc 01.12.2024
    Veröffentlicht in Cancer medicine (Malden, MA) (01.12.2024)
    “… ABSTRACT Backgroud The high cost of blinatumomab in full doses of full treatments has led to dose reduction and fewer treatment cycles for most patients in …”
    Volltext
    Journal Article
  12. 12

    Clinical characteristics of moderate and severe cases with COVID-19 in Wuhan, China: a retrospective study von Sheng, Lingshuang, Wang, Xiong, Tang, Ning, Meng, Fankai, Huang, Liang, Li, Dengju

    ISSN: 1591-8890, 1591-9528, 1591-9528
    Veröffentlicht: Cham Springer International Publishing 01.02.2021
    Veröffentlicht in Clinical and experimental medicine (01.02.2021)
    “… With the outbreak of COVID-19 ongoing, this infectious disease has been posing a significant threat to public health. However, we are still relatively …”
    Volltext
    Journal Article
  13. 13
  14. 14

    CD5 ablation enhances persistence and antitumor potency of engineered T cells by mitigating exhaustion and promoting cytotoxicity von Wu, Jia, Cheng, Jiali, Zhu, Li, Gao, Qiang, Lin, Haolong, Zeng, Yuhao, Li, Yong, Li, Weini, An, Ning, Huang, Liang, Xiao, Min, Li, Dengju, Mu, Wei

    ISSN: 2051-1426, 2051-1426
    Veröffentlicht: England BMJ Publishing Group Ltd 29.11.2025
    Veröffentlicht in Journal for immunotherapy of cancer (29.11.2025)
    “… BackgroundWhile chimeric antigen receptor (CAR)-T cell therapy has transformed the treatment landscape for certain hematologic malignancies, therapeutic …”
    Volltext
    Journal Article
  15. 15

    Study on the Immune Escape Mechanism of Acute Myeloid Leukemia With DNMT3A Mutation von Que, Yimei, Li, Huimin, Lin, Liman, Zhu, Xiaojian, Xiao, Min, Wang, Ying, Zhu, Li, Li, Dengju

    ISSN: 1664-3224, 1664-3224
    Veröffentlicht: Frontiers Media S.A 20.05.2021
    Veröffentlicht in Frontiers in immunology (20.05.2021)
    “… DNA (cytosine-5)-methyltransferase 3A (DNMT3A)-mutated acute myeloid leukemia (AML) has a poor prognosis, but the exact mechanism is still unclear. Here, we …”
    Volltext
    Journal Article
  16. 16

    Efficacy and safety of a novel CD19, CD22 dual-targeted fully human loop bi-CAR-T for the treatment of relapsed/refractory B cell non-Hodgkin lymphoma von Wang, Hanyu, Wang, Gaoxiang, Li, Tongjuan, Zhang, Peiling, Mao, Zekai, Luo, Hui, Zhu, Xiaojian, Li, Dengju, Zhou, Jianfeng, Zhou, Xiaoxi, Huang, Liang

    ISSN: 1479-5876, 1479-5876
    Veröffentlicht: London BioMed Central 05.06.2025
    Veröffentlicht in Journal of translational medicine (05.06.2025)
    “… Background Chimeric antigen receptor (CAR) T-cell therapies targeting CD19 have demonstrated promising efficacy in treating refractory or relapsed B-cell …”
    Volltext
    Journal Article
  17. 17

    Trends in disease burden of chronic myeloid leukemia at the global, regional, and national levels: a population-based epidemiologic study von Ning, Liqing, Hu, Chuanyu, Lu, Pingfan, Que, Yimei, Zhu, Xiaojian, Li, Dengju

    ISSN: 2162-3619, 2162-3619
    Veröffentlicht: London BioMed Central 03.11.2020
    Veröffentlicht in Experimental hematology & oncology (03.11.2020)
    “… Background Outcomes of chronic myeloid leukemia (CML) has been improved dramatically in the past two decades, but survival levels of CML patients varied in …”
    Volltext
    Journal Article
  18. 18

    A multifunctional nanogel encapsulating layered double hydroxide for enhanced osteoarthritis treatment via protection of chondrocytes and ECM von Liu, Changxing, Sun, Yawei, Li, Dengju, Wang, Fan, Wang, Haojue, An, Senbo, Sun, Shui

    ISSN: 2590-0064, 2590-0064
    Veröffentlicht: England Elsevier Ltd 01.06.2024
    Veröffentlicht in Materials today bio (01.06.2024)
    “… Osteoarthritis (OA) is characterized by progressive and irreversible damage to the articular cartilage and a consecutive inflammatory response. However, the …”
    Volltext
    Journal Article
  19. 19

    Rapid genotyping of F8 intron 22 inversion by nested PCR based on long-distance PCR von Wang, Xiong, Hu, Weihong, Gao, Yong, Li, Dengju, Lu, Yanjun

    ISSN: 0929-5305, 1573-742X, 1573-742X
    Veröffentlicht: New York Springer US 01.05.2020
    Veröffentlicht in Journal of thrombosis and thrombolysis (01.05.2020)
    “… F8 intron 22 inversion (Inv22) accounts for about 40% of severe hemophilia A (HA) cases and is mainly genotyped by long-distance PCR (LD-PCR) or inverse-PCR …”
    Volltext
    Journal Article
  20. 20

    Sex-specific cut-off for dilute Russell’s viper venom time lupus anticoagulant test may be of value von Tang, Ning, Luo, Yuanmei, Li, Mangui, Zhu, Mingchao, Li, Dengju

    ISSN: 2475-0379, 2475-0379
    Veröffentlicht: United States Elsevier Inc 01.01.2025
    Veröffentlicht in Research and practice in thrombosis and haemostasis (01.01.2025)
    “… Current guidelines recommend application of the 99th percentile to determine the cut-off value on at least 120 healthy donors regardless of sex for lupus …”
    Volltext
    Journal Article